Table of contents


Top

Editorials

Doing better at doing good p357

doi:10.1038/nbt0408-357

Global health initiatives should place greater emphasis on mechanisms for encouraging small and medium-sized biotech enterprises to participate in the fight against neglected diseases.


A voice with no words p358

doi:10.1038/nbt0408-358

The first blog from a biotech company goes live.


Top

News

US credit crunch impacts biotech across the globe pp359 - 360

Peter Mitchell

doi:10.1038/nbt0408-359


Dynogen's SPAC p360

Randy Osborne

doi:10.1038/nbt0408-360


Can 'double blockbuster' strengthen Amgen's backbone? pp361 - 363

Cormac Sheridan

doi:10.1038/nbt0408-361


Four rebuffs for Cabilly p362

Emily Waltz

doi:10.1038/nbt0408-362a


India's IP snub p362

KS Jayaraman

doi:10.1038/nbt0408-362b


Companies line up for hereditary angioedema market pp364 - 365

Brady Huggett

doi:10.1038/nbt0408-364


Tear-free onions p365

Susan Aldridge

doi:10.1038/nbt0408-365a


Thumbs up for Avastin p365

BJ Spalding

doi:10.1038/nbt0408-365b


Bush tails follow-ons p366

Jeff Fox

doi:10.1038/nbt0408-366a


Amgen's Japan deal p366

Mark Ratner

doi:10.1038/nbt0408-366b


Drug makers chase cancer stem cells pp366 - 367

Charlie Schmidt

doi:10.1038/nbt0408-366c


Profile

Dan Ravicher p369

Crispin Littlehales

doi:10.1038/nbt0408-369

A patent attorney relies on guts, smarts and 'deep throats' to take on what he considers a broken patent system.


News Feature

A mid-life crisis for aging theory pp371 - 374

Ken Garber

doi:10.1038/nbt0408-371

From yeast to mice, limiting food intake slows aging and extends lifespan. Activators of the sirtuins, enzymes famously linked to this process, promise a wealth of new drugs—but the sirtuin hypothesis is now coming under fire. Ken Garber reports.


Top

Bioentrepreneur

Building a business

The seven deadly sins of business development pp375 - 377

Jeffrey J Stewart & Ben Bonifant

doi:10.1038/bioe.2008.3


Top

Opinion and Comment

Correspondence

An inconvenient version of events p379

Giovanni Monastra

doi:10.1038/nbt0408-379a


Response to An inconvenient version of events pp379 - 380

doi:10.1038/nbt0408-379b


Transendothelial movement and caveolae pp380 - 381

Richard G W Anderson

doi:10.1038/nbt0408-380


Response to Transendothelial movement and caveolae pp381 - 382

doi:10.1038/nbt0408-381


Expanding YIC status pp382 - 383

Philippe Pouletty

doi:10.1038/nbt0408-382


Bt corn in Spain—the performance of the EU's first GM crop pp384 - 386

Manuel Gómez-Barbero, Julio Berbel & Emilio Rodríguez-Cerezo

doi:10.1038/nbt0408-384


Commentary

Newtons of the leaves of grass pp387 - 389

Joachim Boldt & Oliver Müller

doi:10.1038/nbt0408-387


Book Review

A bio-friendly future p391

Linda MacDonald Glenn reviews A Many-Colored Glass: Reflections on the Place of Life in the Universe by Freeman J. Dyson

doi:10.1038/nbt0408-391


Top

Feature

Patents

Patenting pluripotence: the next battle for stem cell intellectual property pp393 - 395

Katja Triller Vrtovec & Christopher Thomas Scott

doi:10.1038/nbt0408-393

What will be the impact of induced pluripotent stem cell discoveries on the current stem cell patent landscape?



Top

News and Views

Toward a renewable source of pancreatic beta-cells pp397 - 398

Camillo Ricordi & Helena Edlund

doi:10.1038/nbt0408-397

Insulin-producing cells generated from human embryonic stem cells protect mice from diabetes.

See also: Research by Kroon et al.


Targeting siRNA to arrest fibrosis pp399 - 400

Scott L Friedman

doi:10.1038/nbt0408-399

Vitamin A–mediated targeting of small interfering (si)RNA to stellate cells reverses liver cirrhosis.

See also: Research by Sato et al.


Cancer biomarker profiling with microRNAs pp400 - 401

Stefanie S Jeffrey

doi:10.1038/nbt0408-400

MicroRNAs define tissues of origin in cancer.

See also: Research by Rosenfeld et al.


The oldest antibodies newly discovered pp402 - 403

Zeev Pancer & Roy A Mariuzza

doi:10.1038/nbt0408-402

Lamprey monoclonal antibodies provide stable and high-avidity alternatives to immunoglobulins.


siRNAs with guts pp403 - 405

Ian MacLachlan

doi:10.1038/nbt0408-403

Leukocyte-directed, small interfering (si)RNA against cyclin D1 shows promise for treatment of inflammatory bowel disease.


Research highlights p406

doi:10.1038/nbt0408-406


Top

Computational Biology

Analysis

Discovering microRNAs from deep sequencing data using miRDeep pp407 - 415

Marc R Friedländer, Wei Chen, Catherine Adamidi, Jonas Maaskola, Ralf Einspanier, Signe Knespel & Nikolaus Rajewsky

doi:10.1038/nbt1394


Top

Research

Perspective

Brief Communications

Detecting native folds in mixtures of proteins that contain disulfide bonds pp427 - 429

Mahesh Narayan, Ervin Welker, Huili Zhai, Xuemei Han, Guoqiang Xu, Fred W McLafferty & Harold A Scheraga

doi:10.1038/nbt1380


Articles

Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone pp431 - 442

Yasushi Sato, Kazuyuki Murase, Junji Kato, Masayoshi Kobune, Tsutomu Sato, Yutaka Kawano, Rishu Takimoto, Kouichi Takada, Koji Miyanishi, Takuya Matsunaga, Tetsuji Takayama & Yoshiro Niitsu

doi:10.1038/nbt1396

See also: News and Views by Friedman


Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo pp443 - 452

Evert Kroon, Laura A Martinson, Kuniko Kadoya, Anne G Bang, Olivia G Kelly, Susan Eliazer, Holly Young, Mike Richardson, Nora G Smart, Justine Cunningham, Alan D Agulnick, Kevin A D'Amour, Melissa K Carpenter & Emmanuel E Baetge

doi:10.1038/nbt1393

See also: News and Views by Ricordi & Edlund


Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors pp453 - 461

Johannes L Zakrzewski, David Suh, John C Markley, Odette M Smith, Christopher King, Gabrielle L Goldberg, Robert Jenq, Amanda M Holland, Jeremy Grubin, Javier Cabrera-Perez, Renier J Brentjens, Sydney X Lu, Gabrielle Rizzuto, Derek B Sant'Angelo, Isabelle Riviere, Michel Sadelain, Glenn Heller, Juan Carlos Zúñiga-Pflücker, Chen Lu & Marcel R M van den Brink

doi:10.1038/nbt1395


MicroRNAs accurately identify cancer tissue origin pp462 - 469

Nitzan Rosenfeld, Ranit Aharonov, Eti Meiri, Shai Rosenwald, Yael Spector, Merav Zepeniuk, Hila Benjamin, Norberto Shabes, Sarit Tabak, Asaf Levy, Danit Lebanony, Yaron Goren, Erez Silberschein, Nurit Targan, Alex Ben-Ari, Shlomit Gilad, Netta Sion-Vardy, Ana Tobar, Meora Feinmesser, Oleg Kharenko, Ofer Nativ, Dvora Nass, Marina Perelman, Ady Yosepovich, Bruria Shalmon, Sylvie Polak-Charcon, Eddie Fridman, Amir Avniel, Isaac Bentwich, Zvi Bentwich, Dalia Cohen, Ayelet Chajut & Iris Barshack

doi:10.1038/nbt1392

See also: News and Views by Jeffrey


Erratum

Erratum: Vintage genetic engineering p470

Laura DeFrancesco

doi:10.1038/nbt0408-470a


Corrigendum

Corrigendum: Fluorogen-activating single-chain antibodies for imaging cell surface proteins p470

Christopher Szent-Gyorgyi, Brigitte A Schmidt, Yehuda Creeger, Gregory W Fisher, Kelly L Zakel, Sally Adler, James A J Fitzpatrick, Carol A Woolford, Qi Yan, Kalin V Vasilev, Peter B Berget, Marcel P Bruchez, Jonathan W Jarvik & Alan Waggoner

doi:10.1038/nbt0408-470b


Top

Naturejobs

Careers and Recruitment

Almost in bloom pp471 - 472

Emma Marris

doi:10.1038/nbt0408-471

St. Louis wants to become a hub of agricultural biotechnology. All it needs is more start-ups and funds.


People

People p474

doi:10.1038/nbt0408-474


Top

Extra navigation

Open Innovation Challenges

  • Protect Enzyme from In Planta Degradation

    • Deadline: Jul 15 2009
    • Reward: $20,000 USD

    A proposal for stable expression of an enzyme in corn seed is desired.

  • Corrosion Inhibitor

    • Deadline: Aug 19 2009
    • Reward: $10,000 USD

    The Seeker is looking for inhibitors of corrosion. This Challenge requires only a written descripti...

naturejobs

natureproducts


ADVERTISEMENT